Transgene Biotek Ltd.

View in App
3.97 -0.03 ▼-0.8%

26 May 2023, 04:01:00 PM
Volume: 86,174

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.transgenebiotek.com
Market Cap 30.08 Cr.
Enterprise Value(EV) 42.61 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -0.93 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-12
Industry PE 49.39 Trailing Twelve Months Ending 2022-12
Book Value / Share 1.69 Trailing Twelve Months Ending 2022-12
Price to Book Value 2.34 Calculated using Price: 3.97
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 7.58 Cr. 75,770,000 Shares
FaceValue 10
About Transgene Biotek Ltd.
Transgene Biotek Ltd (TBL) was set up in 1991, and was probably the first true Biotechnology Company in India. It is listed on the Indian Stock Exchanges and is involved in the development of several cutting edge technologies.

Transgene Biotek Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Transgene Biotek Ltd. Performance

View details >>
1 Day
-0.75%
1 Week
+1.28%
1 Month
+60.73%
3 Month
+58.80%
6 Month
+38.81%
1 Year
+13.75%
2 Year
-4.57%
5 Year
+81.28%
10 Year
+118.13%

Transgene Biotek Ltd. Fundamental Ratios

View details >>
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -50.54 -9.63 -11.78 -17.03 -11.57 -18.31 -28.73 -38.00 -52.52
Return on Capital Employed (%) -47.36 -8.84 -10.85 -14.68 -6.74 -14.83 -22.10 -26.55 -32.32
Return on Assets (%) -36.70 -5.45 -6.56 -7.77 -3.35 -4.84 -6.39 -6.45 -6.84

Transgene Biotek Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 206 191 174 59 52 44 33 22 17 14
Non Curr. Liab. 127 127 127 127 120 120 120 120 121 121
Curr. Liab. 26 25 11 12 14 13 14 14 9 10
Minority Int.
Equity & Liab. 358 344 313 198 187 177 167 157 147 145
Non Curr. Assets 338 326 310 197 186 176 166 156 146 144
Curr. Assets 20 18 3 1 1 1 1 1 1 1
Misc. Exp. not W/O
Total Assets 358 344 313 198 187 177 167 157 147 145

Transgene Biotek Ltd. Profit and Loss

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 1 0 0 0 0 0 0 0 0
Other Income 1 0 0 1 7 2 0 0 0 0
Total Income 2 0 0 1 7 2 0 0 0 0
Total Expenditure -3 -2 -1 -3 -2 -1 -1 -1 -1 -1
PBIDT -1 -2 -1 -2 5 1 -1 0 0 -1
Interest 0 0 0 -1 0 0 0 0 0
Depreciation -17 -17 -21 -18 -10 -10 -10 -10 -10 -6
Taxation -1
Exceptional Items -115
PAT -133 -19 -22 -20 -6 -9 -11 -10 -10 -7
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit -133 -19 -22 -20 -6 -9 -11 -10 -10 -7
Adjusted EPS -18 -3 -3 -3 -1 -1 -1 -1 -1 -1

Transgene Biotek Ltd. Cash Flow

View details >>
Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 13 -2 4 6 0 -1 -2 0 0 0
Cash Fr. Inv. -15 1 -5 -6 3 2 0 0
Cash Fr. Finan. 2 1 1 -2 0
Net Change 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0 0

Transgene Biotek Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 23.64 23.64 23.64 23.64 23.64 23.64 23.64 23.64 23.64
Public 76.36 76.36 76.36 76.36 76.36 76.36 76.36 76.36 76.36
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Transgene Biotek Ltd. Announcements

View details >>
Tue, 16 May 2023
Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance.
Fri, 12 May 2023
Board Meeting Intimation for Intimation Of The Board Meeting Of The Company.
TRANSGENE BIOTEK LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve This is to inform you that a meeting of Board of Directors of the Company will be held on Tuesday 30th May 2023.1) To consider and approve the Audited Financial Results of the Company for the Quarter and Financial Year ended 31 st March 2023.2) Any other Business matter with the permission of the Chair.
Fri, 12 May 2023
Intimation Of Non-Applicability Of Regulation 32(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Quarter And Year Ended On 31St March 2023.
Hence the Statement of Deviation or Variation in Public Issue Rights Issue Preferential Issue etc. under Regulation 32(1) of SEBI (Listing Obligations Disclosure Requirements) Regulations 2015 for the quarter and financial year ended 31st March 2023 is not applicable to the Company.

Transgene Biotek Ltd. Technical Scans

View details >>
Fri, 26 May 2023
Opening at High Opening at High
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Above Last Week High Close Above Last Week High
Close Above Last Month High Close Above Last Month High
High Increase in 1 Month High Increase in 1 Month

Transgene Biotek Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 232,891.45 969.90 +2.6%
Divi's Laboratories Ltd. 93,212.66 3,514.00 +2.3%
Cipla Ltd. 76,767.04 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. 75,437.96 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. 66,286.16 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. 57,611.88 1,700.25 -0.1%
Mankind Pharma Ltd. 53,007.87 1,323.60 -0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 27.48 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2023-03 51.00 3,514.00 +2.3%
Cipla Ltd. Consolidated 2023-03 27.40 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 16.74 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 86.68 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 69.29 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 39.70 1,323.60 -0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.16 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2023-03 7.28 3,514.00 +2.3%
Cipla Ltd. Consolidated 2023-03 3.28 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.24 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.75 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 9.03 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 5.10 1,323.60 -0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 0.04 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,323.60 -0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 13.10 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,323.60 -0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 13.10 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,323.60 -0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,323.60 -0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,323.60 -0.3%

Transgene Biotek Ltd. FAQ's

What is Transgene Biotek share price?
Can I buy Transgene Biotek shares now?
What is the Market Cap of Transgene Biotek?
What are the key metrics to analyse Transgene Biotek?
What is the 52 Week High and Low of Transgene Biotek?
What is the trend of Transgene Biotek share price?